RAL was described as an inducer of proliferation in melanoma cell lines, even in the presence of NRAS and/or BRAF oncogenic mutations (Mishra et al., 2010; Zipfel et al., 2010) (Table 1). The gene discussed is BRAF; the disease is melanoma.